Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Mirabegron Sustained-release Tablets

Approval Number

国药准字H20253036

Company重庆医药（集团）股份有限公司

Registration Date

January 2, 2025

Drug Information

Generic Name

米拉贝隆缓释片

Dosage Form

片剂

Strength

50mg

Drug Type

化学药品

Registration Date

January 2, 2025

Company Information

Applicant Company

Company Name重庆医药（集团）股份有限公司

Company Address

重庆市渝中区长江二路12号第三层

Manufacturing Company

Company Name广州玻思韬控释药业有限公司

Company Address

广州市黄埔区瑞祥路228号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy